Literature DB >> 18500167

[Letter fluency: psychometric properties and Dutch normative data].

B Schmand1, S C Groenink, M van den Dungen.   

Abstract

Normative data were collected for a Dutch version of the Controlled Oral Word Association Test (COWAT) in 200 healthy subjects between 17 and 89 years of age. The COWAT is a letterfluency task that is widely used in clinical neuropsychology. Fluency is an important aspect of executive functioning. The psychometric properties of the Dutch version of the test were largely comparable to those of the original COWAT. Its reliability is 0.80, and its scores are significantly related to level of education and/or vocabulary, but not to age or gender. A regression formula is provided by which the raw scores can be corrected for level of education.

Entities:  

Mesh:

Year:  2008        PMID: 18500167     DOI: 10.1007/BF03078128

Source DB:  PubMed          Journal:  Tijdschr Gerontol Geriatr        ISSN: 0167-9228


  51 in total

1.  Long-term evaluation of cognition after glioma surgery in eloquent areas.

Authors:  Djaina Satoer; Evy Visch-Brink; Marion Smits; Alfred Kloet; Caspar Looman; Clemens Dirven; Arnaud Vincent
Journal:  J Neurooncol       Date:  2013-10-31       Impact factor: 4.130

2.  Executive Functions in Older Adults With Autism Spectrum Disorder: Objective Performance and Subjective Complaints.

Authors:  Roeliena C D Davids; Yvonne Groen; Ina J Berg; Oliver M Tucha; Ingrid D C van Balkom
Journal:  J Autism Dev Disord       Date:  2016-09

Review 3.  A Systematic Review of Normative Data for Verbal Fluency Test in Different Languages.

Authors:  Dolores Villalobos; Lucia Torres-Simón; Javier Pacios; Nuria Paúl; David Del Río
Journal:  Neuropsychol Rev       Date:  2022-09-13       Impact factor: 6.940

4.  Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients.

Authors:  Marlies van Nimwegen; Arlène D Speelman; Katrijn Smulders; Sebastiaan Overeem; George F Borm; Frank J G Backx; Bastiaan R Bloem; Marten Munneke
Journal:  BMC Neurol       Date:  2010-08-19       Impact factor: 2.474

5.  What is measured with verbal fluency tests in Parkinson's disease patients at different stages of the disease?

Authors:  Janneke Koerts; Hester A Meijer; Katrien S F Colman; Lara Tucha; Klaus W Lange; Oliver Tucha
Journal:  J Neural Transm (Vienna)       Date:  2012-08-26       Impact factor: 3.575

6.  Executive functioning in daily life in Parkinson's disease: initiative, planning and multi-task performance.

Authors:  Janneke Koerts; Marije Van Beilen; Oliver Tucha; Klaus L Leenders; Wiebo H Brouwer
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

7.  Imaging of neuroinflammation due to repetitive head injury in currently active kickboxers.

Authors:  Gilles N Stormezand; Janine Doorduin; Sandra E Rakers; Jacoba M Spikman; Joukje van der Naalt; David Vállez García; Anouk van der Hoorn; Chris W J van der Weijden; Berry P H Kremer; Remco J Renken; Rudi A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-15       Impact factor: 10.057

8.  Cognitive function, depression, fatigue and quality of life among long-term survivors of head and neck cancer.

Authors:  Joyce Wilbers; Arnoud C Kappelle; Laura Versteeg; Anil M Tuladhar; Stefan C A Steens; Frederick J A Meijer; Willem Boogerd; Lucille D Dorresteijn; Johannes H Kaanders; Roy P C Kessels; Ewoud J van Dijk
Journal:  Neurooncol Pract       Date:  2015-05-07

9.  Cognitive adaptation training provided to chronically hospitalized patients with schizophrenia in the Netherlands: two case reports.

Authors:  Piotr J Quee; Harald Schneider; Saskia van Slogteren; Durk Wiersma; Richard Bruggeman; Dawn I Velligan
Journal:  Case Rep Psychiatry       Date:  2012-10-02

10.  Rotterdam Aphasia Therapy Study (RATS)-3: "The efficacy of intensive cognitive-linguistic therapy in the acute stage of aphasia"; design of a randomised controlled trial.

Authors:  Femke Nouwens; Diederik Wj Dippel; Marjolein de Jong-Hagelstein; Evy G Visch-Brink; Peter J Koudstaal; Lonneke M L de Lau
Journal:  Trials       Date:  2013-01-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.